J. Goldman & CO LP Deciphera Pharmaceuticals, Inc. Transaction History
J. Goldman & CO LP
- $3.21 Billion
- Q3 2024
A detailed history of J. Goldman & CO LP transactions in Deciphera Pharmaceuticals, Inc. stock. As of the latest transaction made, J. Goldman & CO LP holds 27,000 shares of DCPH stock, worth $0. This represents 0.01% of its overall portfolio holdings.
Number of Shares
27,000Holding current value
$0% of portfolio
0.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding DCPH
# of Institutions
6Shares Held
293KCall Options Held
500Put Options Held
0-
Jefferies Group LLC New York, NY175KShares$00.03% of portfolio
-
Virginia Retirement Systems Et Al Richmond, VA81KShares$00.01% of portfolio
-
Credit Suisse Ag Zurich, V836KShares$00.0% of portfolio
-
Cutler Group LP300Shares$00.0% of portfolio
-
Wipfli Financial Advisors Llc,204Shares$00.0% of portfolio
About Deciphera Pharmaceuticals, Inc.
- Ticker DCPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 66,822,100
- Description
- Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...